نتایج جستجو برای: tuberculosis vaccine

تعداد نتایج: 204686  

2011
Suraj B. Sable Mani Cheruvu Subhadra Nandakumar Sunita Sharma Kakali Bandyopadhyay Kathryn L. Kellar James E. Posey Bonnie B. Plikaytis Rama Rao Amara Thomas M. Shinnick

BACKGROUND The identification of Mycobacterium tuberculosis vaccines that elicit a protective immune response in the lungs is important for the development of an effective vaccine against tuberculosis. METHODS AND PRINCIPAL FINDINGS In this study, a comparison of intranasal (i.n.) and subcutaneous (s.c.) vaccination with the BCG vaccine demonstrated that a single moderate dose delivered intra...

2013
Sun Myung Joung Sungweon Ryoo

The anti-tuberculosis Bacille de Calmette et Guérin (BCG) vaccine was developed between 1905 and 1921 at Pasteur Institutes of Lille in France, and was adopted by many countries. BCG strains comprise natural mutants of major virulence factors of Mycobacterium tuberculosis and that BCG sub-strains differ markedly in virulence levels. The tuberculosis became endemic in Korea after the Korean War ...

Journal: :The Indian journal of medical research 2003
P Prem Raj S Srivastava S K Jain B S Srivastava R Srivastava

BACKGROUND & OBJECTIVES In recent years the efficacy of BCG vaccine against tuberculosis has been questioned and there is no alternative vaccine available. Several strategies are being applied to get a satisfactory vaccine. Two approaches are generally considered: the subunit vaccines and the whole cell vaccines. The objective of this investigation was to evaluate an avirulent mycobacteria, Myc...

Journal: :PLoS Pathogens 2009
Crystal Y. Chen Dan Huang Richard C. Wang Ling Shen Gucheng Zeng Shuyun Yao Yun Shen Lisa Halliday Jeff Fortman Milton McAllister Jim Estep Robert Hunt Daphne Vasconcelos George Du Steven A. Porcelli Michelle H. Larsen William R. Jacobs Barton F. Haynes Norman L. Letvin Zheng W. Chen

The role of CD8 T cells in anti-tuberculosis immunity in humans remains unknown, and studies of CD8 T cell-mediated protection against tuberculosis in mice have yielded controversial results. Unlike mice, humans and nonhuman primates share a number of important features of the immune system that relate directly to the specificity and functions of CD8 T cells, such as the expression of group 1 C...

2013
Ana Paula Junqueira-Kipnis Fábio Muniz de Oliveira Monalisa Martins Trentini Sangeeta Tiwari Bing Chen Danilo Pires Resende Bruna D. S. Silva Mei Chen Lydia Tesfa William R. Jacobs André Kipnis

The development of a new vaccine as a substitute for Bacillus Calmette-Guerin or to improve its efficacy is one of the many World Health Organization goals to control tuberculosis. Mycobacterial vectors have been used successfully in the development of vaccines against tuberculosis. To enhance the potential utility of Mycobacterium smegmatis as a vaccine, it was transformed with a recombinant p...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000
T Lietman S M Blower

We use 2 simple mathematical models (one a preexposure vaccine model and the other a postexposure vaccine model) to provide general insight into the effects of vaccination on tuberculosis epidemics. We discuss how these models can be used as health policy tools: to identify which vaccines are "equivalent," to design control strategies, and to predict the epidemiological impact of different vacc...

2005
D. A. Mitchison

It is appropriate to consider progress in the control of tuberculosis on March 24th, World Tuberculosis Day. While an effective vaccine that would kill dormant tubercle bacilli would be a real solution to eradication of the disease, progress in vaccine development is very slow and unlikely to produce a new vaccine with this desirable property in the near future. Control of the disease therefore...

Journal: :Infection and immunity 2003
Jennifer L Taylor Oliver C Turner Randall J Basaraba John T Belisle Kris Huygen Ian M Orme

The use of DNA constructs encoding mycobacterial proteins is a promising new approach to vaccination against tuberculosis. A DNA vaccine encoding the hsp60 molecule of Mycobacterium leprae has previously been shown to protect against intravenous infection of mice with Mycobacterium tuberculosis in both the prophylactic and immunotherapeutic modes. It is shown here, however, that this vaccine wa...

2011
Mairaj Ahmed Ansari Swaleha Zubair Anjum Mahmood Pushpa Gupta Aijaz A. Khan Umesh D. Gupta Ashish Arora Mohammad Owais

BACKGROUND The absence of certain genomic loci that are present in most of the virulent strains of Mycobacterium tuberculosis as well as lack of lasting memory responses are some of the major causes attributed to the non effectiveness of Bacille Calmette-Gue'rin (BCG) vaccine. Immunization schedules addressing these issues can offer better strategy for protection against tuberculosis. METHODS...

Journal: :PLoS ONE 2008
Jesús Gonzalo-Asensio Serge Mostowy Jose Harders-Westerveen Kris Huygen Rogelio Hernández-Pando Jelle Thole Marcel Behr Brigitte Gicquel Carlos Martín

Inactivation of the transcriptional regulator PhoP results in Mycobacterium tuberculosis attenuation. Preclinical testing has shown that attenuated M. tuberculosis phoP mutants hold promise as safe and effective live vaccine candidates. We focused this study to decipher the virulence networks regulated by PhoP. A combined transcriptomic and proteomic analysis revealed that PhoP controls a varie...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید